Compared with smear microscopy, Xpert® MTB/RIF has the potential to reduce delays in tuberculosis (TB) diagnosis and treatment initiation, and improve treatment outcomes. The authors reviewed publications comparing treatment outcomes of drug-susceptible TB patients diagnosed using Xpert vs. smear.
This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)
Harries AD, Takarinda KC. F1000Prime Recommendation of [Agizew T et al., Int J Tuberc Lung Dis 2019 23(1):82-92]. F1000Prime. 2019. Available from: https://f1000.com/prime/734946505#eval793557528
Treatment outcomes, diagnostic and therapeutic impact: Xpert vs. smear. A systematic review and meta-analysis